86 related articles for article (PubMed ID: 26238234)
1. Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.
Gordon JA; Midha A; Szeitz A; Ghaffari M; Adomat HH; Guo Y; Klassen TL; Guns ES; Wasan KM; Cox ME
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):21-7. PubMed ID: 26238234
[TBL] [Abstract][Full Text] [Related]
2. Methylselenocysteine preventing castration-resistant progression of prostate cancer.
Liu Y; Liu X; Guo Y; Liang Z; Tian Y; Lu L; Zhao X; Sun Y; Zhao X; Zhang H; Dong Y
Prostate; 2015 Jun; 75(9):1001-8. PubMed ID: 25754033
[TBL] [Abstract][Full Text] [Related]
3. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
[TBL] [Abstract][Full Text] [Related]
4. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.
Yang Y; Bai Y; He Y; Zhao Y; Chen J; Ma L; Pan Y; Hinten M; Zhang J; Karnes RJ; Kohli M; Westendorf JJ; Li B; Zhu R; Huang H; Xu W
Clin Cancer Res; 2018 Feb; 24(4):834-846. PubMed ID: 29167276
[No Abstract] [Full Text] [Related]
5. Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells.
Höti N; Yang S; Hu Y; Shah P; Haffner MC; Zhang H
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):137-146. PubMed ID: 29339807
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.
Sissung TM; Ley AM; Strope JD; McCrea EM; Beedie S; Peer CJ; Shukla S; van Velkinburgh J; Reece K; Troutman S; Campbell T; Fernandez E; Huang P; Smith J; Thakkar N; Venzon DJ; Brenner S; Lee W; Merino M; Luo J; Jager W; Price DK; Chau CH; Figg WD
Mol Cancer Res; 2017 Aug; 15(8):1096-1105. PubMed ID: 28389619
[TBL] [Abstract][Full Text] [Related]
7. Overcoming Resistance in Prostate Cancer Therapy Using a DZ-Simvastatin Conjugate.
Ou Y; Chu GC; Lyu J; Yin L; Lim A; Zhai N; Cui X; Lewis MS; Edderkaoui M; Pandol SJ; Wang R; Zhang Y
Mol Pharm; 2024 Feb; 21(2):873-882. PubMed ID: 38229228
[TBL] [Abstract][Full Text] [Related]
8. Adverse Effects of Pharmacological Therapy of Benign Prostatic Hyperplasia on Sexual Function in Men.
Stojanović N; Ignjatović I; Djenić N; Bogdanović D
Srp Arh Celok Lek; 2015; 143(5-6):284-9. PubMed ID: 26259400
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
11. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
Elsby R; Martin P; Surry D; Sharma P; Fenner K
Drug Metab Dispos; 2016 Mar; 44(3):398-408. PubMed ID: 26700956
[TBL] [Abstract][Full Text] [Related]
12. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
Nash SH; Till C; Song X; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Platz EA; Schenk J
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1507-15. PubMed ID: 26269564
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis.
Huang W; Xue P; Zong H; Zhang Y
Br J Clin Pharmacol; 2016 Jan; 81(1):13-22. PubMed ID: 26255996
[TBL] [Abstract][Full Text] [Related]
14. A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
Wang L; Gong Y; Chippada-Venkata U; Heck MM; Retz M; Nawroth R; Galsky M; Tsao CK; Schadt E; de Bono J; Olmos D; Zhu J; Oh WK
BMC Med; 2015 Aug; 13():201. PubMed ID: 26297150
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Deng Q; Tang DG
Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
[TBL] [Abstract][Full Text] [Related]
16. Drug therapies for metastatic castration-resistant prostate cancer.
El-Bahesh E; Finianos A; Alfaraj A; Aragon-Ching JB
Future Oncol; 2015; 11(17):2395-403. PubMed ID: 26274603
[TBL] [Abstract][Full Text] [Related]
17. Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.
Martin AM; Nirschl TR; Nirschl CJ; Francica BJ; Kochel CM; van Bokhoven A; Meeker AK; Lucia MS; Anders RA; DeMarzo AM; Drake CG
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):325-32. PubMed ID: 26260996
[TBL] [Abstract][Full Text] [Related]
18. Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia.
Ballard KD; Lorson L; White CM; Thompson PD; Taylor BA
Adv Prev Med; 2015; 2015():351059. PubMed ID: 26257959
[TBL] [Abstract][Full Text] [Related]
19. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review.
Sharma M; Bennett C; Carter B; Cohen SN
J Am Acad Dermatol; 2015 Oct; 73(4):710-716.e4. PubMed ID: 26253363
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer.
Gordon JA; Noble JW; Midha A; Derakhshan F; Wang G; Adomat HH; Tomlinson Guns ES; Lin YY; Ren S; Collins CC; Nelson PS; Morrissey C; Wasan KM; Cox ME
Cancer Res; 2019 Jul; 79(13):3320-3331. PubMed ID: 31064850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
